Molecular and Serological Characterization of the SARS-CoV-2 Delta Variant in Bangladesh in 2021

Novel SARS-CoV-2 variants are emerging at an alarming rate. The delta variant and other variants of concern (VoC) carry spike (S)-protein mutations, which have the potential to evade protective immunity, to trigger break-through infections after COVID-19 vaccination, and to propagate future waves of...

Full description

Saved in:
Bibliographic Details
Published inViruses Vol. 13; no. 11; p. 2310
Main Authors Ghosh, Asish Kumar, Kaiser, Marco, Molla, Md. Maruf Ahmed, Nafisa, Tasnim, Yeasmin, Mahmuda, Ratul, Rifat Hossain, Sharif, Md. Mohiuddin, Akram, Arifa, Hosen, Nur, Mamunur, Rashid, Amin, Md. Robed, Islam, Alimul, Hoque, Md. Ehsanul, Landt, Olfert, Lytton, Simon D.
Format Journal Article
LanguageEnglish
Published Basel MDPI AG 19.11.2021
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Novel SARS-CoV-2 variants are emerging at an alarming rate. The delta variant and other variants of concern (VoC) carry spike (S)-protein mutations, which have the potential to evade protective immunity, to trigger break-through infections after COVID-19 vaccination, and to propagate future waves of COVID-19 pandemic. To identify SARS CoV-2 variants in Bangladesh, patients who are RT-PCR-positive for COVID-19 infections in Dhaka were screened by a RT-PCR melting curve analysis for spike protein mutations. To assess the anti-SARS CoV-2 antibody responses, the levels of the anti-S -proteins IgA and IgG and the anti-N-protein IgG were measured by ELISA. Of a total of 36 RT-PCR positive samples (75%), 27 were identified as delta variants, with one carrying an additional Q677H mutation and two with single nucleotide substitutions at position 23029 (compared to Wuhan-Hu-1 reference NC 045512) in the genome sequence. Three (8.3%) were identified as beta variants, two (5.5%) were identified as alpha variants, three (8.3%) were identified as having a B.1.1.318 lineage, and one sample was identified as an eta variant (B.1.525) carrying an additional V687L mutation. The trend of higher viral load (lower Cp values) among delta variants than in the alpha and beta variants was of borderline statistical significance (p = 0.045). Prospective studies with larger Bangladeshi cohorts are warranted to confirm the emergence of S-protein mutations and their association with antibody response in natural infection and potential breakthrough in vaccinated subjects.
AbstractList Novel SARS-CoV-2 variants are emerging at an alarming rate. The delta variant and other variants of concern (VoC) carry spike (S)-protein mutations, which have the potential to evade protective immunity, to trigger break-through infections after COVID-19 vaccination, and to propagate future waves of COVID-19 pandemic. To identify SARS CoV-2 variants in Bangladesh, patients who are RT-PCR-positive for COVID-19 infections in Dhaka were screened by a RT-PCR melting curve analysis for spike protein mutations. To assess the anti-SARS CoV-2 antibody responses, the levels of the anti-S -proteins IgA and IgG and the anti-N-protein IgG were measured by ELISA. Of a total of 36 RT-PCR positive samples (75%), 27 were identified as delta variants, with one carrying an additional Q677H mutation and two with single nucleotide substitutions at position 23029 (compared to Wuhan-Hu-1 reference NC 045512) in the genome sequence. Three (8.3%) were identified as beta variants, two (5.5%) were identified as alpha variants, three (8.3%) were identified as having a B.1.1.318 lineage, and one sample was identified as an eta variant (B.1.525) carrying an additional V687L mutation. The trend of higher viral load (lower Cp values) among delta variants than in the alpha and beta variants was of borderline statistical significance ( p = 0.045). Prospective studies with larger Bangladeshi cohorts are warranted to confirm the emergence of S-protein mutations and their association with antibody response in natural infection and potential breakthrough in vaccinated subjects.
Novel SARS-CoV-2 variants are emerging at an alarming rate. The delta variant and other variants of concern (VoC) carry spike (S)-protein mutations, which have the potential to evade protective immunity, to trigger break-through infections after COVID-19 vaccination, and to propagate future waves of COVID-19 pandemic. To identify SARS CoV-2 variants in Bangladesh, patients who are RT-PCR-positive for COVID-19 infections in Dhaka were screened by a RT-PCR melting curve analysis for spike protein mutations. To assess the anti-SARS CoV-2 antibody responses, the levels of the anti-S -proteins IgA and IgG and the anti-N-protein IgG were measured by ELISA. Of a total of 36 RT-PCR positive samples (75%), 27 were identified as delta variants, with one carrying an additional Q677H mutation and two with single nucleotide substitutions at position 23029 (compared to Wuhan-Hu-1 reference NC 045512) in the genome sequence. Three (8.3%) were identified as beta variants, two (5.5%) were identified as alpha variants, three (8.3%) were identified as having a B.1.1.318 lineage, and one sample was identified as an eta variant (B.1.525) carrying an additional V687L mutation. The trend of higher viral load (lower Cp values) among delta variants than in the alpha and beta variants was of borderline statistical significance (p = 0.045). Prospective studies with larger Bangladeshi cohorts are warranted to confirm the emergence of S-protein mutations and their association with antibody response in natural infection and potential breakthrough in vaccinated subjects.
Novel SARS-CoV-2 variants are emerging at an alarming rate. The delta variant and other variants of concern (VoC) carry spike (S)-protein mutations, which have the potential to evade protective immunity, to trigger break-through infections after COVID-19 vaccination, and to propagate future waves of COVID-19 pandemic. To identify SARS CoV-2 variants in Bangladesh, patients who are RT-PCR-positive for COVID-19 infections in Dhaka were screened by a RT-PCR melting curve analysis for spike protein mutations. To assess the anti-SARS CoV-2 antibody responses, the levels of the anti-S -proteins IgA and IgG and the anti-N-protein IgG were measured by ELISA. Of a total of 36 RT-PCR positive samples (75%), 27 were identified as delta variants, with one carrying an additional Q677H mutation and two with single nucleotide substitutions at position 23029 (compared to Wuhan-Hu-1 reference NC 045512) in the genome sequence. Three (8.3%) were identified as beta variants, two (5.5%) were identified as alpha variants, three (8.3%) were identified as having a B.1.1.318 lineage, and one sample was identified as an eta variant (B.1.525) carrying an additional V687L mutation. The trend of higher viral load (lower Cp values) among delta variants than in the alpha and beta variants was of borderline statistical significance (p = 0.045). Prospective studies with larger Bangladeshi cohorts are warranted to confirm the emergence of S-protein mutations and their association with antibody response in natural infection and potential breakthrough in vaccinated subjects.Novel SARS-CoV-2 variants are emerging at an alarming rate. The delta variant and other variants of concern (VoC) carry spike (S)-protein mutations, which have the potential to evade protective immunity, to trigger break-through infections after COVID-19 vaccination, and to propagate future waves of COVID-19 pandemic. To identify SARS CoV-2 variants in Bangladesh, patients who are RT-PCR-positive for COVID-19 infections in Dhaka were screened by a RT-PCR melting curve analysis for spike protein mutations. To assess the anti-SARS CoV-2 antibody responses, the levels of the anti-S -proteins IgA and IgG and the anti-N-protein IgG were measured by ELISA. Of a total of 36 RT-PCR positive samples (75%), 27 were identified as delta variants, with one carrying an additional Q677H mutation and two with single nucleotide substitutions at position 23029 (compared to Wuhan-Hu-1 reference NC 045512) in the genome sequence. Three (8.3%) were identified as beta variants, two (5.5%) were identified as alpha variants, three (8.3%) were identified as having a B.1.1.318 lineage, and one sample was identified as an eta variant (B.1.525) carrying an additional V687L mutation. The trend of higher viral load (lower Cp values) among delta variants than in the alpha and beta variants was of borderline statistical significance (p = 0.045). Prospective studies with larger Bangladeshi cohorts are warranted to confirm the emergence of S-protein mutations and their association with antibody response in natural infection and potential breakthrough in vaccinated subjects.
Author Sharif, Md. Mohiuddin
Akram, Arifa
Hosen, Nur
Landt, Olfert
Mamunur, Rashid
Amin, Md. Robed
Lytton, Simon D.
Islam, Alimul
Ratul, Rifat Hossain
Kaiser, Marco
Yeasmin, Mahmuda
Ghosh, Asish Kumar
Hoque, Md. Ehsanul
Molla, Md. Maruf Ahmed
Nafisa, Tasnim
AuthorAffiliation 7 SeraDiaLogistics, 81545 Munich, Germany
6 TIB Molbiol GmbH, Eresburgstraße 22-23, 12103 Berlin, Germany; OLandt@tib-molbiol.de
1 Department of Virology, Dhaka Medical College Hospital, Dhaka 1000, Bangladesh; asish127kumar@gmail.com (A.K.G.); dr.ratulrifat@gmail.com (R.H.R.); mohiuddinsharif@pircc.org (M.M.S.); robedamin@yahoo.com (M.R.A.)
4 Bangladesh Institute Tropical Infectious Disease (BITID), Fouzderhat, Chittagong 4317, Bangladesh; mamunurdr30@gmail.com
2 GenExpress Gesellschaft für Proteindesign GmbH, Eresburgstraße 22-23 D, 12103 Berlin, Germany; kaiser@genexpress.de
3 National Institute of Laboratory Medicine and Referral Center, Sher E-Bangla Nagar, Dhaka 1207, Bangladesh; maruf063@gmail.com (M.M.A.M.); nafisahf3@gmail.com (T.N.); shumi.yeasmin@gmail.com (M.Y.); drbarna43@gmail.com (A.A.); nurhosen568@gmail.com (N.H.); nilmrc@ld.dghs.gov.bd (M.E.H.)
5 Department of Microbiology and Hygiene, Faculty of Veterinary Science, Bangladesh Agricultural University, Mymensingh 2202, Bangl
AuthorAffiliation_xml – name: 5 Department of Microbiology and Hygiene, Faculty of Veterinary Science, Bangladesh Agricultural University, Mymensingh 2202, Bangladesh; alimul.vmh@bau.edu.bd
– name: 3 National Institute of Laboratory Medicine and Referral Center, Sher E-Bangla Nagar, Dhaka 1207, Bangladesh; maruf063@gmail.com (M.M.A.M.); nafisahf3@gmail.com (T.N.); shumi.yeasmin@gmail.com (M.Y.); drbarna43@gmail.com (A.A.); nurhosen568@gmail.com (N.H.); nilmrc@ld.dghs.gov.bd (M.E.H.)
– name: 7 SeraDiaLogistics, 81545 Munich, Germany
– name: 1 Department of Virology, Dhaka Medical College Hospital, Dhaka 1000, Bangladesh; asish127kumar@gmail.com (A.K.G.); dr.ratulrifat@gmail.com (R.H.R.); mohiuddinsharif@pircc.org (M.M.S.); robedamin@yahoo.com (M.R.A.)
– name: 4 Bangladesh Institute Tropical Infectious Disease (BITID), Fouzderhat, Chittagong 4317, Bangladesh; mamunurdr30@gmail.com
– name: 2 GenExpress Gesellschaft für Proteindesign GmbH, Eresburgstraße 22-23 D, 12103 Berlin, Germany; kaiser@genexpress.de
– name: 6 TIB Molbiol GmbH, Eresburgstraße 22-23, 12103 Berlin, Germany; OLandt@tib-molbiol.de
Author_xml – sequence: 1
  givenname: Asish Kumar
  orcidid: 0000-0001-5735-3606
  surname: Ghosh
  fullname: Ghosh, Asish Kumar
– sequence: 2
  givenname: Marco
  surname: Kaiser
  fullname: Kaiser, Marco
– sequence: 3
  givenname: Md. Maruf Ahmed
  orcidid: 0000-0002-5062-9144
  surname: Molla
  fullname: Molla, Md. Maruf Ahmed
– sequence: 4
  givenname: Tasnim
  surname: Nafisa
  fullname: Nafisa, Tasnim
– sequence: 5
  givenname: Mahmuda
  surname: Yeasmin
  fullname: Yeasmin, Mahmuda
– sequence: 6
  givenname: Rifat Hossain
  surname: Ratul
  fullname: Ratul, Rifat Hossain
– sequence: 7
  givenname: Md. Mohiuddin
  surname: Sharif
  fullname: Sharif, Md. Mohiuddin
– sequence: 8
  givenname: Arifa
  surname: Akram
  fullname: Akram, Arifa
– sequence: 9
  givenname: Nur
  surname: Hosen
  fullname: Hosen, Nur
– sequence: 10
  givenname: Rashid
  surname: Mamunur
  fullname: Mamunur, Rashid
– sequence: 11
  givenname: Md. Robed
  orcidid: 0000-0002-5500-5103
  surname: Amin
  fullname: Amin, Md. Robed
– sequence: 12
  givenname: Alimul
  orcidid: 0000-0002-6186-8044
  surname: Islam
  fullname: Islam, Alimul
– sequence: 13
  givenname: Md. Ehsanul
  surname: Hoque
  fullname: Hoque, Md. Ehsanul
– sequence: 14
  givenname: Olfert
  surname: Landt
  fullname: Landt, Olfert
– sequence: 15
  givenname: Simon D.
  orcidid: 0000-0001-5617-4139
  surname: Lytton
  fullname: Lytton, Simon D.
BookMark eNqNkktvEzEURkeoiD5gwT8YiQ0shvo99gaphAKVipAIdGtu7TuJI8cuHqdS-fVMmoJo2bDy63xH1_Y9bPZSTtg0zyl5zbkhx9eUU8o4JY-aA2qM6YShcu-v-X5zOI4rQpQypH_S7HOhuaRUHTTfP-WIbhOhtJB8O8eSY14EB7GdLaGAq1jCT6ghpzYPbV1iOz_5Mu9m-aJj7TuMFdoLKAFSbUNq30JaRPA4LrcrRhh92jweII747G48ar69P_06-9idf_5wNjs575zoTe2kBj8MntGpxktURjvnwTiQnAhFaC-p1w6l4EiAkkELz3FAzxkMKIEZftSc7bw-w8pelbCGcmMzBHu7kcvCQqnBRbSTTRg_pRQdhNBCe66Uc7xXUhFOhsn1Zue62lyu0TtMtUC8J71_ksLSLvK11YpxTeUkeHknKPnHBsdq12F0GCMkzJvRMsWV5KLn-j9QIgiTQqkJffEAXeVNSdOrbinGhCSSTdTxjnIlj2PBwbpQbz9wKjVES4ndNo390zRT4tWDxO-b_sv-Au1IvsM
CitedBy_id crossref_primary_10_1128_jvi_01618_23
crossref_primary_10_1093_infdis_jiad320
crossref_primary_10_1177_02601060221124068
crossref_primary_10_3390_v16071077
crossref_primary_10_3390_vaccines10111959
crossref_primary_10_1016_j_heliyon_2024_e31011
crossref_primary_10_1038_s41598_023_34188_7
crossref_primary_10_1021_acsestwater_2c00103
crossref_primary_10_1631_jzus_B2200054
Cites_doi 10.1016/j.meegid.2021.104884
10.1038/s41591-021-01377-8
10.1038/d41586-020-03626-1
10.1093/molbev/msy096
10.1128/MRA.00524-21
10.3389/fmicb.2020.584251
10.1056/NEJMoa2108891
10.1186/s41182-021-00360-w
10.1101/2021.06.16.21259017
10.3390/pathogens10060637
10.1136/bmjgh-2020-004206
10.1101/2021.06.28.21258780
10.1038/s41579-021-00573-0
10.1002/gch2.1018
10.1016/j.compbiolchem.2021.107533
10.3390/ijerph18126503
10.1101/2020.12.28.20248906
10.1128/MRA.00100-21
10.3390/v13071192
10.1186/s12939-021-01520-4
10.1038/s41564-020-0770-5
10.1038/s41591-021-01449-9
10.1038/s41467-021-26479-2
10.3390/ijms22116150
10.1038/s41591-021-01410-w
10.1016/j.virusres.2021.198390
10.1007/s00705-021-05166-z
10.1016/j.plabm.2021.e00212
10.1128/MRA.00496-21
10.1016/j.infpip.2021.100159
10.1016/j.heliyon.2021.e07385
ContentType Journal Article
Copyright 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2021 by the authors. 2021
Copyright_xml – notice: 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2021 by the authors. 2021
DBID AAYXX
CITATION
3V.
7U9
7X7
7XB
88E
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
COVID
DWQXO
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M1P
M7P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
7S9
L.6
5PM
DOA
DOI 10.3390/v13112310
DatabaseName CrossRef
ProQuest Central (Corporate)
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central (New)
Natural Science Collection
ProQuest One Community College
Coronavirus Research Database
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
ProQuest Health & Medical Collection
PML(ProQuest Medical Library)
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Coronavirus Research Database
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList
CrossRef
MEDLINE - Academic
AGRICOLA
Publicly Available Content Database

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1999-4915
ExternalDocumentID oai_doaj_org_article_17549d5a261f44848d366cc37656030f
PMC8623815
10_3390_v13112310
GeographicLocations Bangladesh
United States--US
China
Germany
India
GeographicLocations_xml – name: China
– name: Germany
– name: Bangladesh
– name: United States--US
– name: India
GroupedDBID ---
2WC
53G
5VS
7X7
88E
8FE
8FH
8FI
8FJ
A8Z
AADQD
AAFWJ
AAHBH
AAYXX
ABDBF
ABUWG
ACUHS
AFKRA
AFPKN
AFZYC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
BBNVY
BENPR
BHPHI
BPHCQ
BVXVI
CCPQU
CITATION
DIK
E3Z
EBD
ESX
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
HYE
IAO
IHR
ITC
KQ8
LK8
M1P
M48
M7P
MODMG
M~E
O5R
O5S
OK1
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RPM
TR2
TUS
UKHRP
3V.
7U9
7XB
8FK
AZQEC
COVID
DWQXO
GNUQQ
H94
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
7X8
7S9
L.6
5PM
PUEGO
ID FETCH-LOGICAL-c479t-58adffd21066be698ccda9ca5304601751d8ce543e0a10f84d3efed32afe5a293
IEDL.DBID M48
ISSN 1999-4915
IngestDate Wed Aug 27 01:30:56 EDT 2025
Thu Aug 21 18:34:01 EDT 2025
Mon Jul 21 11:30:26 EDT 2025
Thu Jul 10 19:11:11 EDT 2025
Fri Jul 25 12:05:33 EDT 2025
Tue Jul 01 02:48:29 EDT 2025
Thu Apr 24 23:06:47 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Language English
License https://creativecommons.org/licenses/by/4.0
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c479t-58adffd21066be698ccda9ca5304601751d8ce543e0a10f84d3efed32afe5a293
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
A.K.G. and M.K. gave equal contribution to the work and both are recognized as first authors.
ORCID 0000-0002-6186-8044
0000-0001-5617-4139
0000-0001-5735-3606
0000-0002-5500-5103
0000-0002-5062-9144
OpenAccessLink https://doaj.org/article/17549d5a261f44848d366cc37656030f
PMID 34835116
PQID 2602245052
PQPubID 2032319
ParticipantIDs doaj_primary_oai_doaj_org_article_17549d5a261f44848d366cc37656030f
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8623815
proquest_miscellaneous_2636534738
proquest_miscellaneous_2604025466
proquest_journals_2602245052
crossref_citationtrail_10_3390_v13112310
crossref_primary_10_3390_v13112310
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20211119
PublicationDateYYYYMMDD 2021-11-19
PublicationDate_xml – month: 11
  year: 2021
  text: 20211119
  day: 19
PublicationDecade 2020
PublicationPlace Basel
PublicationPlace_xml – name: Basel
PublicationTitle Viruses
PublicationYear 2021
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References Rambaut (ref_16) 2020; 5
Kames (ref_10) 2020; 10
Nagy (ref_35) 2021; 166
Brochot (ref_42) 2020; 11
ref_36
ref_13
Sarkar (ref_32) 2021; 10
Das (ref_34) 2021; 93
Pritchard (ref_11) 2021; 27
Bartok (ref_41) 2021; 94
Siam (ref_7) 2021; 7
ref_19
ref_18
Jahan (ref_29) 2021; 29
ref_17
ref_38
ref_15
ref_37
Kumar (ref_40) 2018; 35
Hasan (ref_30) 2021; 297
Hossain (ref_31) 2021; 10
Harvey (ref_12) 2021; 19
Saha (ref_25) 2021; 6
Wei (ref_39) 2021; 12
ref_24
Islam (ref_27) 2021; 92
Khoury (ref_22) 2021; 27
Bednarczyk (ref_45) 2021; 25
ref_43
Rella (ref_9) 2021; 11
ref_20
Rahman (ref_26) 2021; 1
Elbe (ref_14) 2017; 1
Daria (ref_33) 2021; 3
ref_1
Ball (ref_3) 2021; 589
Wilson (ref_8) 2020; 5
Thanh (ref_4) 2020; 19
Marinho (ref_5) 2021; 20
ref_2
ref_28
Bernal (ref_23) 2021; 385
Hammerschmidt (ref_21) 2021; 27
Egbert (ref_44) 2021; 4
ref_6
References_xml – volume: 92
  start-page: 104884
  year: 2021
  ident: ref_27
  article-title: Assessment of basic reproduction number (R0), spatial and temporal epidemiological determinants, and genetic characterization of SARS-CoV-2 in Bangladesh
  publication-title: Infect. Genet. Evol.
  doi: 10.1016/j.meegid.2021.104884
– volume: 6
  start-page: e006012
  year: 2021
  ident: ref_25
  article-title: COVID-19 rise in Bangladesh correlates with increasing detection of B.1.351 variant
  publication-title: Brit. Med. J. Glob. Health
– volume: 27
  start-page: 1205
  year: 2021
  ident: ref_22
  article-title: Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
  publication-title: Nat. Med.
  doi: 10.1038/s41591-021-01377-8
– volume: 589
  start-page: 16
  year: 2021
  ident: ref_3
  article-title: The speedy approach used to tackle SARS-CoV-2 could change the future of vaccine science
  publication-title: Nature
  doi: 10.1038/d41586-020-03626-1
– ident: ref_24
– volume: 35
  start-page: 1547
  year: 2018
  ident: ref_40
  article-title: MEGA X: Molecular evolutionary genetics analysis across computing platforms
  publication-title: Mol. Biol. Evol.
  doi: 10.1093/molbev/msy096
– volume: 1
  start-page: 1
  year: 2021
  ident: ref_26
  article-title: The emergence of SARS-CoV-2 variants in Dhaka city, Bangladesh
  publication-title: Transbound. Emerg. Dis.
– volume: 10
  start-page: e00524-21
  year: 2021
  ident: ref_32
  article-title: Genome sequence of a SARS-CoV-2 P.1 variant of concern (20J/501Y.V3) from Bangladesh
  publication-title: Microbiol. Resour. Announc.
  doi: 10.1128/MRA.00524-21
– volume: 11
  start-page: 584251
  year: 2020
  ident: ref_42
  article-title: Anti-spike, anti-nucleocapsid and neutralizing antibodies in SARS-CoV-2 in patients and asymptomatic individuals
  publication-title: Front. Microbiol.
  doi: 10.3389/fmicb.2020.584251
– volume: 385
  start-page: 585
  year: 2021
  ident: ref_23
  article-title: Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa2108891
– ident: ref_28
  doi: 10.1186/s41182-021-00360-w
– ident: ref_38
  doi: 10.1101/2021.06.16.21259017
– ident: ref_43
  doi: 10.3390/pathogens10060637
– volume: 5
  start-page: e004206
  year: 2020
  ident: ref_8
  article-title: Social media and vaccine hesitancy
  publication-title: BMJ Glob. Health
  doi: 10.1136/bmjgh-2020-004206
– ident: ref_13
  doi: 10.1101/2021.06.28.21258780
– volume: 94
  start-page: 388
  year: 2021
  ident: ref_41
  article-title: Correlation between a quantitative SARS CoV-2 IgG ELISA and neutralization activity
  publication-title: J. Med. Virol.
– volume: 19
  start-page: 409
  year: 2021
  ident: ref_12
  article-title: COVID-19 Genomics UK (COG-UK) Consortium, Peacock SJ and Robertson DL, SARS-CoV-2 variants, spike mutations and immune escape
  publication-title: Nat. Rev. Microbiol.
  doi: 10.1038/s41579-021-00573-0
– ident: ref_1
– volume: 1
  start-page: 33
  year: 2017
  ident: ref_14
  article-title: Data, disease and diplomacy: GISAID’s innovative contribution to global health
  publication-title: Glob. Chall.
  doi: 10.1002/gch2.1018
– ident: ref_18
– volume: 93
  start-page: 10753
  year: 2021
  ident: ref_34
  article-title: Molecular insight into the genomic variation of SARS-CoV-2 strains from current outbreak
  publication-title: Comput. Biol. Chem.
  doi: 10.1016/j.compbiolchem.2021.107533
– volume: 19
  start-page: 305
  year: 2020
  ident: ref_4
  article-title: The COVID-19 vaccine development landscape
  publication-title: Nat. Rev.
– ident: ref_6
  doi: 10.3390/ijerph18126503
– ident: ref_36
  doi: 10.1101/2020.12.28.20248906
– volume: 10
  start-page: e00100-21
  year: 2021
  ident: ref_31
  article-title: Genome sequence of a SARS-CoV-2 strain from Bangladesh that is nearly identical to United Kingdom SARS-CoV-2 variant B.1.1.7
  publication-title: Microbiol. Resour. Announc.
  doi: 10.1128/MRA.00100-21
– ident: ref_37
  doi: 10.3390/v13071192
– volume: 20
  start-page: 183
  year: 2021
  ident: ref_5
  article-title: Determinants of access to the SARS-CoV-2 vaccine: A preliminary approach
  publication-title: Int. J. Equity Health
  doi: 10.1186/s12939-021-01520-4
– volume: 5
  start-page: 1403
  year: 2020
  ident: ref_16
  article-title: A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology
  publication-title: Nat. Microbiol.
  doi: 10.1038/s41564-020-0770-5
– volume: 27
  start-page: 1525
  year: 2021
  ident: ref_21
  article-title: Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination
  publication-title: Nat. Med.
  doi: 10.1038/s41591-021-01449-9
– volume: 12
  start-page: 6250
  year: 2021
  ident: ref_39
  article-title: Anti-spike antibody response to natural SARS-CoV-2 infection in the general population
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-021-26479-2
– ident: ref_2
– ident: ref_15
  doi: 10.3390/ijms22116150
– volume: 27
  start-page: 1370
  year: 2021
  ident: ref_11
  article-title: Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom
  publication-title: Nat. Med.
  doi: 10.1038/s41591-021-01410-w
– volume: 297
  start-page: 198390
  year: 2021
  ident: ref_30
  article-title: Global and local mutations in Bangladeshi SARS-CoV-2 genomes
  publication-title: Virus Res.
  doi: 10.1016/j.virusres.2021.198390
– volume: 166
  start-page: 2541
  year: 2021
  ident: ref_35
  article-title: Evolutionary insights into the furin cleavage sites of SARS-CoV-2 variants from humans and animals
  publication-title: Arch. Virol.
  doi: 10.1007/s00705-021-05166-z
– volume: 25
  start-page: e00212
  year: 2021
  ident: ref_45
  article-title: The real life performance of 7 automated anti-SARS-CoV-2 IgG and IgM/IgA immunoassays
  publication-title: Pract. Lab. Med.
  doi: 10.1016/j.plabm.2021.e00212
– ident: ref_17
– ident: ref_19
– volume: 10
  start-page: 15643
  year: 2020
  ident: ref_10
  article-title: Sequence analysis of SARS-CoV-2 genome reveals features important for vaccine design
  publication-title: Nat. Sci. Rep.
– volume: 11
  start-page: 15279
  year: 2021
  ident: ref_9
  article-title: Rates of SARS-CoV-2 transmission and vaccination impact the fate of vaccine-resistant strains
  publication-title: Nat. Sci. Rep.
– volume: 29
  start-page: e00496-21
  year: 2021
  ident: ref_29
  article-title: Genomic surveillance of SARS-CoV-2 viruses collected during the ending phase of the first wave of the COVID-19 pandemic in Bangladesh
  publication-title: Microbiol. Resour. Announc.
  doi: 10.1128/MRA.00496-21
– volume: 4
  start-page: e2123256
  year: 2021
  ident: ref_44
  article-title: Durability of spike immunoglobin G antibodies to SARS-CoV-2 among health care workers with prior infection
  publication-title: JAMA
– ident: ref_20
– volume: 3
  start-page: 100159
  year: 2021
  ident: ref_33
  article-title: Bangladesh reported delta variant of coronavirus among its citizen: Actionable items to tackle the potential massive third wave
  publication-title: Infect. Prev. Pract.
  doi: 10.1016/j.infpip.2021.100159
– volume: 7
  start-page: e07385
  year: 2021
  ident: ref_7
  article-title: Insights into the first seven-months of COVID-19 pandemic in Bangladesh: Lessons learned from a high risk country
  publication-title: Heliyon
  doi: 10.1016/j.heliyon.2021.e07385
SSID ssj0066907
Score 2.3410945
Snippet Novel SARS-CoV-2 variants are emerging at an alarming rate. The delta variant and other variants of concern (VoC) carry spike (S)-protein mutations, which have...
SourceID doaj
pubmedcentral
proquest
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
StartPage 2310
SubjectTerms amino acid mutations
Amino acids
anti-N-protein IgG
anti-S-protein IgG
antibodies
antibody formation
Antibody response
Bangladesh
Coronaviruses
COVID-19
COVID-19 infection
COVID-19 vaccines
delta variant
Developing countries
Disease transmission
Genomes
Immunoglobulin A
Immunoglobulin G
Infections
Influenza
LDCs
Manufacturers
Melting curve
Mutation
Nucleotide sequence
nucleotide sequences
Pandemics
Phylogenetics
Polymerase chain reaction
Proteins
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Software
Spike protein
Vaccination
viral load
Viruses
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LS8QwEA4iCF7EJ9YXUTx4KXY3j6ZHXRUR9OALbzVNJihIV9xV8N870xcWRC8em8whnUwy30eSbxjbdyakPqMXy0ObxNImEBdpYWLjERz4gQKt6TXy5ZU-v5MXD-rhW6kvuhNWywPXjjvE9CYzrywi_YBUQhovtHYO1wXmapEE2n0x57Vkqt6DNXG-WkdIIKk__CBRGUIyvexTifT3kGX_XuS3RHO2yBYahMiP6pEtsRkol9lcXTPyc4U9XrYFbbktPce13m5ffNSJL9dvK_k4cMR3_Obo-iYeje_jIT-Bl6nl90iQ0aP8ueTHlqp4eJg80dcQc_Equzs7vR2dx02ZhNjJNJvGylgfgkfuhn4FnRnnvM2cVdWhJ_pv4I0DJQUkdpAEI72AAF4MbQD0aybW2Gw5LmGdcZsBtkqTiEJJEigAk6aqQJgQVJEmELGD1n25azTEqZTFS45cgjydd56O2F5n-loLZ_xkdExz0BmQ1nXVgBGQNxGQ_xUBEdtqZzBvFuAkR5qG4ISq9EVst-vGpUPnIbaE8XtlI0kMQOvfbIRWQqbCRCztRUdv0P2e8vmpEupGtoiASG38x19usnmKAXoGOci22Oz07R22EQ9Ni50q9L8AOT4GFQ
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagCIkL4ikCBRnEgYvVZP3MCbULVYVUDpRWewuOPW4rVUnpbiv13zOTF0RCPcaegzNje76xPd8w9jG4ZGNJGcsLnwvlcxC1rZ1wEcFBLDQYQ9nIh9_NwbH6ttKr4cBtPTyrHPfEbqOObaAz8h3E3ehtqOza58vfgqpG0e3qUELjPntA1GX0pMuupoDLUOTXswlJDO13bohahvDMzAd1VP0zfDl_HfmPu9l_wh4POJHv9oZ9yu5B84w97CtH3j5nvw7HsrbcN5Hjih83Mb6cKJj7DEveJo4ojx_t_jgSy_ZELPgXuNh4foJhMuqVnzd8z1MtjwjrM_paoEd-wY73v_5cHoihWIIIypYboZ2PKUWM4FC7YEoXQvRl8Lq7-kSQUEQXQCsJuS_y5FSUkCDKhU-gPTr9l2yraRt4xbgvAVuVy2WtFdEUgLNW1wgWkq5tDhn7NKqvCgOTOBW0uKgwoiBNV5OmM_ZhEr3s6TP-J7RHNpgEiPG6a2ivTqthAVX4B6qMOFJTJAwplYvSmBBwf0TMJvOUse3RgtWwDNfV30mTsfdTNy4guhXxDbTXnYwiSgBj7pKRRktlpcuYnc2O2aDnPc35WUfXjTEjwiL9-u4BvmGPyLqU5liU22xrc3UNbxHvbOp33aT-A-QO_yE
  priority: 102
  providerName: ProQuest
Title Molecular and Serological Characterization of the SARS-CoV-2 Delta Variant in Bangladesh in 2021
URI https://www.proquest.com/docview/2602245052
https://www.proquest.com/docview/2604025466
https://www.proquest.com/docview/2636534738
https://pubmed.ncbi.nlm.nih.gov/PMC8623815
https://doaj.org/article/17549d5a261f44848d366cc37656030f
Volume 13
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1ba9RAFD70guCLtF4wtl1G8cGXaLKZWx5EumtrEbZI65Z9i5PMjC0sid1ui_33npMbBor4EkhyAsmZnJnvy2S-D-Btob2yKa1YHpso5CZyYa5yHWqL4MDGwklJq5Fnp_Jkzr8uxGIDOo_NNoE3D1I78pOar5bvf1_ff8KC_0iMEyn7hzuSjCGcsgnbOCApqs8Z7ycTJBHAenI5JUO1WDQCQ8NLB8NSrd4_gJzDHyb_GoGOd-BJCx3ZYdPWu7DhyqfwqDGTvH8GP2ad0y0zpWXYCXT9Gpv2qszNoktWeYbAj50fnp2H0-oiHLPPbrk27AKZM6aaXZVsYsjew7qbS9ob4yD9HObHR9-nJ2HrnxAWXKXrUGhjvbdI6jDhTqa6KKxJCyPq2VDEDbHVhRM8cZGJI6-5TZx3Nhkb74RBHPACtsqqdC-BmdThUa6jJBecEum0UiJH_OBFriIXwLsufVnRiouTx8UyQ5JBmc76TAfwpg_91ShqPBQ0oTboA0gEuz5QrX5mbU1l-AQ8tXinMvbIMrm2iZRFgV0mwrgk8gHsdy2YdS9WhvwNUQvZ9wXwuj-NNUUTJaZ01W0dw0klQMp_xSRSJFwlOgA1eDsGNz08U15d1greSCMRKYlX_5OKPXhMbUzrH-N0H7bWq1t3gEBonY9gUy3UCLYnR6ffzkb15wTcflnEo7oA_gBG8Ahc
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELaqrRBcEE8RKGAQSFyiJvEjzgGh7rbVlnZXqC_1ljp-0EpVUrpbUP8Uv5GZvCAS6q3HJHNwPOPxN3Hm-wj5YJRPbYYdy4mOQq4jFxZpoUJlARzYWDgpsRt5NpfTI_71RJyskN9dLwz-VtnlxDpR28rgN_J1wN2w26Ds2pfLHyGqRuHpaieh0YTFrrv5BSXb4vPOJvj3Y5Jsbx1OpmGrKhAanmbLUChtvbdQ6sAwnMyUMVZnRov6jBB209gq4wRnLtJx5BW3zHlnWaK9EzpB8iVI-aucgfGIrI635t_2u9wvsdZs-IsYy6L1n0hmgwhqsOvV4gADRDv8H_OfDW77EXnYIlO60YTSY7LiyifkXqNVefOUnM46IV2qS0shx3Rpk0560uemp5NWngKupAcb-wfhpDoOE7rpLpaaHkNhDp6k5yUda1QPsW5xhlcJYIBn5OhOJvI5GZVV6V4QqjMHd7mKWCE4EiM4laaiAHjiRZFGLiCfuunLTctdjhIaFznUMDjTeT_TAXnfm142hB3_MxqjD3oD5Niub1RX3_N2yebwBjyzMFIZeyhiubJMSmMgIwNKZJEPyFrnwbxd-Iv8b5gG5F3_GJYsnsPo0lXXtQ1HEgIpb7NhUjCeMhWQdBAdg0EPn5TnZzVBOFSpAMTEy9sH-Jbcnx7O9vK9nfnuK_IAPY1NlnG2RkbLq2v3GtDWsnjThjglp3e9qv4Am5w-tQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bT9RAFJ4QjMYX4zWuoI5GE1-abTvXPhgDu25AhBgRsm9lOhcgIS2wi4a_5q_znN60ieGNx07Pw3TOZb7TmfMdQt5ZHZTLsGI5NXHETeyjQhU60g7AgUuElxKrkXf35NYB_zIX8xXyu6uFwWuVXUysA7WrLP4jHwPuht0G266NQ3st4tt09un8IsIOUnjS2rXTaExkx1__gvRt8XF7Crp-n6azzz8mW1HbYSCyXGXLSGjjQnCQ9sCUvMy0tc5k1oj6vBB21sRp6wVnPjZJHDR3zAfvWGqCFyZFIiYI_3cUEwn6mJr3yZ7ErLNhMmIsi8c_kdYGsdRg_6vbBAyw7fBm5j9b3ewhedBiVLrRGNUjsuLLx-Ru07Xy-gk52u1a6lJTOgrRpgugdNLTPzfVnbQKFBAm3d_4vh9NqsMopVN_tjT0EFJ00Ck9LemmwT4izi9O8CkFNPCUHNzKMj4jq2VV-ueEmszDKNcxKwRHigSvlRIFAJUgChX7EfnQLV9uWxZzbKZxlkM2gyud9ys9Im970fOGuuN_Qpuog14A2bbrgeryOG-dN4cv4JmDmcokQDrLtWNSWguxGfAii8OIrHcazNsQsMj_GuyIvOlfg_PiiYwpfXVVy3CkI5DyJhkmBeOK6RFRA-sYTHr4pjw9qanCIV8FSCZe3DzB1-Qe-FL-dXtvZ43cR0VjtWWSrZPV5eWVfwmwa1m8qu2bkqPbdqg_2CNBhQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Molecular+and+Serological+Characterization+of+the+SARS-CoV-2+Delta+Variant+in+Bangladesh+in+2021&rft.jtitle=Viruses&rft.au=Ghosh%2C+Asish+Kumar&rft.au=Kaiser%2C+Marco&rft.au=Molla%2C+Md.+Maruf+Ahmed&rft.au=Nafisa%2C+Tasnim&rft.date=2021-11-19&rft.issn=1999-4915&rft.eissn=1999-4915&rft.volume=13&rft.issue=11&rft.spage=2310&rft_id=info:doi/10.3390%2Fv13112310&rft.externalDBID=n%2Fa&rft.externalDocID=10_3390_v13112310
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1999-4915&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1999-4915&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1999-4915&client=summon